Result of AGM

Pharma C Investments PLC

27 September 2023

 

27 September 2023

Result of General Meeting

Pharma C Investments Plc ("Pharma C" or the "Company") announces that, further to the announcement of 22 September 2023, at the general meeting ("GM") held today at the offices of Hill Dickinson LLP, the resolutions were withdrawn and not put to members as the requisition convening the GM was withdrawn.

Prior to the requisition being withdrawn, the Company had received the following proxy appointments:

	Chairman of the meeting FOR		Chairman of the meeting AGAINST		Chairman of the meeting DISCRETION		ABSTAIN
	Cards	Votes	Cards	Votes	Cards	Votes	Cards	Votes
Ordinary Resolution 1	0	0	3	52,637,360	1	1,428,571	0	0
Ordinary Resolution 2	0	0	4	54,065,931	0	0	0	0
Ordinary Resolution 3	0	0	4	54,065,931	0	0	0	0

Further to the announcement made on 30 June 2023, the Company announces that it continues to work with its auditors to publish its audited financial statements for the year ended 31 December 2022 and will provide updates in due course.

This announcement contains inside information for the purposes of Article 7 of the Market Abuse Regulation (EU) 596/2014 as it forms part of UK domestic law by virtue of the European Union (Withdrawal) Act 2018 ("MAR"), and is disclosed in accordance with the Company's obligations under Article 17 of MAR.

The Directors of Pharma C accept responsibility for this announcement.

END

For additional information please contact:

Pharma C Investments

Gavin Sathianathan, Investment Strategy Director

[e-mail]

Novum Securities (AQSE Corporate Adviser)

Tel: [phone]

David Coffman 

 

END